Viewing Study NCT03751202


Ignite Creation Date: 2025-12-25 @ 3:56 AM
Ignite Modification Date: 2026-02-28 @ 10:35 PM
Study NCT ID: NCT03751202
Status: COMPLETED
Last Update Posted: 2018-12-28
First Post: 2018-11-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Bioequivalence Study Between Fluticasone Salmeterol Xinafoate vs. ADVAIR DISKUSĀ® in Healthy Volunteers
Sponsor: Respirent Pharmaceuticals Co Ltd.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: BECRO/RESP/BREATH-PK500
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View